ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
CAV1 |
CAV1, CAV: Caveolin-1 |
9.722 |
Evidence |
O
|
RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
9.677 |
Evidence |
O
|
RANBP5 |
|
KPNA4 |
QIP1, KPNA4: Importin subunit alpha-4 |
9.642 |
Evidence |
O
|
MYBL2 |
MYBL2, BMYB: Myb-related protein B |
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
9.637 |
Evidence |
O
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
9.552 |
Evidence |
O
|
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
9.43 |
Evidence |
O
|
RP4-691N24.2 |
GINS1, KIAA0186, PSF1: DNA replication complex GINS protein PSF1 |
SLD5 |
GINS4, SLD5: DNA replication complex GINS protein SLD5 |
9.395 |
Evidence |
O
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
9.387 |
Evidence |
O
|
F2 |
F2: Prothrombin precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
9.35 |
Evidence |
O
|
MSN |
MSN: Moesin |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
9.325 |
Evidence |
O
|
PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
9.325 |
Evidence |
O
|
HDLBP |
HDLBP, HBP, VGL: Vigilin |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
9.307 |
Evidence |
O
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
9.297 |
Evidence |
O
|
RB1 |
RB1: Retinoblastoma-associated protein |
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
9.177 |
Evidence |
O
|
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
9.165 |
Evidence |
O
|
COPB2 |
COPB2: Coatomer subunit beta' |
CCT6A |
CCT6A, CCT6, CCTZ: T-complex protein 1 subunit zeta |
9.165 |
Evidence |
O
|
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
EIF3S8 |
EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 |
9.165 |
Evidence |
O
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
9.165 |
Evidence |
O
|
IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
9.142 |
Evidence |
O
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
9.0 |
Evidence |
O
|
U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
8.98 |
Evidence |
O
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
8.962 |
Evidence |
O
|
JUND |
JUND: Transcription factor jun-D |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
8.922 |
Evidence |
O
|
UBE2L3 |
UBE2L3, UBCE7, UBCH7: Ubiquitin-conjugating enzyme E2 L3 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
8.92 |
Evidence |
O
|
VIL2 |
IPI00479359 |
RDX |
RDX: Radixin |
8.867 |
Evidence |
O
|